Paras Healthcare on Tuesday announced the appointment of DebajitSensharma as Group Chief Financial Officer, who will be responsible for strategising organizational growth and expansion plans.
With over 28 years of experience in the field of finance and accounts, Debajit has a rich experience in working with healthcare and pharma majors, such as Ranbaxy Laboratories Ltd, Sentiss PharmaPvt Ltd. ,Symbiotec Pharmalab Pvt. Ltd and consumer goods major, Reckitt Benckiser Group.
"We are delighted to have Debajit join our team. His expertise infinancial planning and budgeting, mergers and acquisitions, fund raising, business structuring, and investment planning will be much needed to further our expansion plans and direct healthcare delivery operations towards newer areas," said Dr. Dharminder Nagar, MD, Paras Healthcare.
"I am excited about my new role at Paras Healthcare, which has been at the forefront of quality medical care delivery to the common man. My endeavors would be to put to use my experience in pharma and healthcare industry and further Dr. Nagar's plans for the organization," said Debajit Sensharma on his appointment.
Disclaimer: No Business Standard Journalist was involved in creation of this content
